Literature DB >> 15651768

Antenatal HIV testing: evaluation of uptake and women's attitudes in a low risk population.

G McCracken1, J McGeagh, R Roberts.   

Abstract

The number of HIV-positive heterosexuals in the UK is increasing, with a resultant increase in the number of pregnant women who are HIV-positive. The benefits of diagnosing an HIV-positive woman antenatally are well established. The Department of Health of England issued guidelines recommending named voluntary antenatal testing, with a view to achieving a maternal diagnosis rate of 90% by December 2002. In Northern Ireland the policy was distributed in 2003. The screening programme in our hospital had an uptake rate of 98.7 %. Responses to a questionnaire to evaluate the process indicate that HIV testing was associated with low levels of anxiety and that patients were well satisfied with the counselling they received.

Entities:  

Mesh:

Year:  2004        PMID: 15651768      PMCID: PMC2475467     

Source DB:  PubMed          Journal:  Ulster Med J        ISSN: 0041-6193


  7 in total

1.  Mode of delivery and the risk of vertical transmission of HIV-1.

Authors:  K P Beckerman; A B Morris; A Stek
Journal:  N Engl J Med       Date:  1999-07-15       Impact factor: 91.245

2.  Antenatal HIV testing: assessment of a routine voluntary approach.

Authors:  W M Simpson; F D Johnstone; D J Goldberg; S M Gormley; G J Hart
Journal:  BMJ       Date:  1999-06-19

3.  Uptake and acceptability of antenatal HIV testing: randomised controlled trial of different methods of offering the test.

Authors:  W M Simpson; F D Johnstone; F M Boyd; D J Goldberg; G J Hart; R J Prescott
Journal:  BMJ       Date:  1998-01-24

4.  Voluntary universal antenatal HIV testing.

Authors:  D Mercey; B A Helps; A Copas; A Petruckevitch; A M Johnson; J Spencer
Journal:  Br J Obstet Gynaecol       Date:  1996-11

5.  Women's attitudes to HIV screening in pregnancy in an area of low prevalence.

Authors:  Swati Jha; Harry Gee; Aravinthan Coomarasamy
Journal:  BJOG       Date:  2003-02       Impact factor: 6.531

6.  Risk of human immunodeficiency virus type 1 transmission through breastfeeding.

Authors:  D T Dunn; M L Newell; A E Ades; C S Peckham
Journal:  Lancet       Date:  1992-09-05       Impact factor: 79.321

7.  Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

Authors:  E M Connor; R S Sperling; R Gelber; P Kiselev; G Scott; M J O'Sullivan; R VanDyke; M Bey; W Shearer; R L Jacobson
Journal:  N Engl J Med       Date:  1994-11-03       Impact factor: 91.245

  7 in total
  1 in total

1.  Acceptability of perinatal rapid point-of-care HIV testing in an area of low HIV prevalence in the UK.

Authors:  Suzy H M Stokes; Paddy McMaster; Khaled M K Ismail
Journal:  Arch Dis Child       Date:  2007-02-09       Impact factor: 3.791

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.